Cargando…

Epidemiology of type 2 diabetes in India

The burden of diabetes is high and increasing globally, and in developing economies like India, mainly fueled by the increasing prevalence of overweight/obesity and unhealthy lifestyles. The estimates in 2019 showed that 77 million individuals had diabetes in India, which is expected to rise to over...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradeepa, Rajendra, Mohan, Viswanathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725109/
https://www.ncbi.nlm.nih.gov/pubmed/34708726
http://dx.doi.org/10.4103/ijo.IJO_1627_21
_version_ 1784626046936547328
author Pradeepa, Rajendra
Mohan, Viswanathan
author_facet Pradeepa, Rajendra
Mohan, Viswanathan
author_sort Pradeepa, Rajendra
collection PubMed
description The burden of diabetes is high and increasing globally, and in developing economies like India, mainly fueled by the increasing prevalence of overweight/obesity and unhealthy lifestyles. The estimates in 2019 showed that 77 million individuals had diabetes in India, which is expected to rise to over 134 million by 2045. Approximately 57% of these individuals remain undiagnosed. Type 2 diabetes, which accounts for majority of the cases, can lead to multiorgan complications, broadly divided into microvascular and macrovascular complications. These complications are a significant cause for increased premature morbidity and mortality among individuals with diabetes, leading to reduced life expectancy and financial and other costs of diabetes leading to profound economic burden on the Indian health care system. The risk for diabetes is largely influence by ethnicity, age, obesity and physical inactivity, unhealthy diet, and behavioral habits in addition to genetics and family history. Good control of blood sugar blood pressure and blood lipid levels can prevent and/or delay the onset of diabetes complications. The prevention and management of diabetes and associated complications is a huge challenge in India due to several issues and barriers, including lack of multisectoral approach, surveillance data, awareness regarding diabetes, its risk factors and complications, access to health care settings, access to affordable medicines, etc. Thus, effective health promotion and primary prevention, at both, individual and population levels are the need of the hour to curb the diabetes epidemic and reduce diabetes-related complications in India.
format Online
Article
Text
id pubmed-8725109
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-87251092022-01-20 Epidemiology of type 2 diabetes in India Pradeepa, Rajendra Mohan, Viswanathan Indian J Ophthalmol Review Article The burden of diabetes is high and increasing globally, and in developing economies like India, mainly fueled by the increasing prevalence of overweight/obesity and unhealthy lifestyles. The estimates in 2019 showed that 77 million individuals had diabetes in India, which is expected to rise to over 134 million by 2045. Approximately 57% of these individuals remain undiagnosed. Type 2 diabetes, which accounts for majority of the cases, can lead to multiorgan complications, broadly divided into microvascular and macrovascular complications. These complications are a significant cause for increased premature morbidity and mortality among individuals with diabetes, leading to reduced life expectancy and financial and other costs of diabetes leading to profound economic burden on the Indian health care system. The risk for diabetes is largely influence by ethnicity, age, obesity and physical inactivity, unhealthy diet, and behavioral habits in addition to genetics and family history. Good control of blood sugar blood pressure and blood lipid levels can prevent and/or delay the onset of diabetes complications. The prevention and management of diabetes and associated complications is a huge challenge in India due to several issues and barriers, including lack of multisectoral approach, surveillance data, awareness regarding diabetes, its risk factors and complications, access to health care settings, access to affordable medicines, etc. Thus, effective health promotion and primary prevention, at both, individual and population levels are the need of the hour to curb the diabetes epidemic and reduce diabetes-related complications in India. Wolters Kluwer - Medknow 2021-11 2021-10-29 /pmc/articles/PMC8725109/ /pubmed/34708726 http://dx.doi.org/10.4103/ijo.IJO_1627_21 Text en Copyright: © 2021 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Pradeepa, Rajendra
Mohan, Viswanathan
Epidemiology of type 2 diabetes in India
title Epidemiology of type 2 diabetes in India
title_full Epidemiology of type 2 diabetes in India
title_fullStr Epidemiology of type 2 diabetes in India
title_full_unstemmed Epidemiology of type 2 diabetes in India
title_short Epidemiology of type 2 diabetes in India
title_sort epidemiology of type 2 diabetes in india
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725109/
https://www.ncbi.nlm.nih.gov/pubmed/34708726
http://dx.doi.org/10.4103/ijo.IJO_1627_21
work_keys_str_mv AT pradeeparajendra epidemiologyoftype2diabetesinindia
AT mohanviswanathan epidemiologyoftype2diabetesinindia